Recent 52-Week High Exceeded in Shares of McKesson (MCK)
McKesson (NYSE:MCK) traded today at a new 52-week high of $159.84. This new high was reached on below average trading volume as 141,000 shares traded hands, while the average 30-day volume is approximately 2.1 million shares.
McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
In the past 52 weeks, McKesson share prices have been bracketed by a low of $90.60 and a high of $159.84 and are now at $159.24, 76% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 2.1%.
There is potential upside of 8.0% for shares of McKesson based on a current price of $159.24 and an average consensus analyst price target of $171.93. The stock should find initial support at its 50-day moving average (MA) of $140.42 and further support at its 200-day MA of $119.80.
SmarTrend recommended that subscribers consider buying shares of McKesson on July 11th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $118.13. Since that recommendation, shares of McKesson have risen 35.0%. We continue to monitor MCK for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows McKesson